A review of healthcare plan operator Hapvida's planned buyout of rival Smile will be extended for an additional 90 days, following a request from national competition authority Council Luis Henrique Bertolino Braido.The Tribunal of the Administrative Council for Economic Defense, or CADE, must ratify his decision — a mere formality of the